Thiel Capital, the investment office of Peter Thiel, has invested in biotech group, EnClear Therapies. Thiel Capital seeded the US group with three other investors with $4 million.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in